Jimeng Hu

569 total citations
23 papers, 422 citations indexed

About

Jimeng Hu is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jimeng Hu has authored 23 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jimeng Hu's work include Cancer-related molecular mechanisms research (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Medicinal Plant Pharmacodynamics Research (4 papers). Jimeng Hu is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Medicinal Plant Pharmacodynamics Research (4 papers). Jimeng Hu collaborates with scholars based in China, Australia and United States. Jimeng Hu's co-authors include Tian Yang, Mengbo Hu, Qiang Ding, Haowen Jiang, Chen Yang, Lujia Zou, Hua Xu, Shanhua Mao, Xiaobo Wu and Yuxi Ou and has published in prestigious journals such as Molecular Therapy, BioMed Research International and Annals of Surgical Oncology.

In The Last Decade

Jimeng Hu

23 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jimeng Hu China 12 227 172 109 63 51 23 422
Peide Bai China 12 265 1.2× 237 1.4× 151 1.4× 104 1.7× 59 1.2× 31 499
Mengbo Hu China 11 119 0.5× 109 0.6× 77 0.7× 65 1.0× 40 0.8× 27 309
Jinchun Xing China 12 206 0.9× 101 0.6× 178 1.6× 49 0.8× 32 0.6× 40 491
Yongchang Lai China 13 277 1.2× 140 0.8× 260 2.4× 101 1.6× 44 0.9× 37 505
Jieping Hu China 13 230 1.0× 102 0.6× 193 1.8× 70 1.1× 16 0.3× 38 431
Ran Zhuo China 8 173 0.8× 118 0.7× 70 0.6× 31 0.5× 21 0.4× 23 328
Sergio Berzal Spain 8 160 0.7× 43 0.3× 53 0.5× 26 0.4× 25 0.5× 8 375
Boxing Su China 11 191 0.8× 121 0.7× 111 1.0× 75 1.2× 11 0.2× 28 397
Baoxing Liu China 14 388 1.7× 299 1.7× 129 1.2× 96 1.5× 29 0.6× 51 687
Carol Jones United States 11 120 0.5× 104 0.6× 122 1.1× 37 0.6× 36 0.7× 15 352

Countries citing papers authored by Jimeng Hu

Since Specialization
Citations

This map shows the geographic impact of Jimeng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jimeng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jimeng Hu more than expected).

Fields of papers citing papers by Jimeng Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jimeng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jimeng Hu. The network helps show where Jimeng Hu may publish in the future.

Co-authorship network of co-authors of Jimeng Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Jimeng Hu. A scholar is included among the top collaborators of Jimeng Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jimeng Hu. Jimeng Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Chen, Siqi Wu, Zezhong Mou, et al.. (2022). Exosome-derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironments. Molecular Therapy. 30(3). 1054–1070. 127 indexed citations
2.
Liang, Yingchun, Yang Chen, Fangdie Ye, et al.. (2022). Repair of the Urethral Mucosa Defect Model Using Adipose-Derived Stem Cell Sheets and Monitoring the Fate of Indocyanine Green-Labeled Sheets by Near Infrared-II. ACS Biomaterials Science & Engineering. 8(11). 4909–4920. 5 indexed citations
3.
Zou, Lujia, Rong‐Zong Liu, Chenyang Xu, et al.. (2021). Ureteroscopic Cryoablation for Patients with Upper Tract Urothelial Carcinoma of a Solitary Kidney: A Porcine Model and Our Pilot Clinical Experience. Annals of Surgical Oncology. 28(13). 9201–9208. 5 indexed citations
4.
Wu, Xiaobo, Xingbo Long, Chen Yang, et al.. (2020). Icaritin reduces prostate cancer progression via inhibiting high-fat diet-induced serum adipokine in TRAMP mice model. Journal of Cancer. 11(22). 6556–6564. 7 indexed citations
5.
Chen, Yang, Zheyu Zhang, Fangdie Ye, et al.. (2020). FGF18 Inhibits Clear Cell Renal Cell Carcinoma Proliferation and Invasion via Regulating Epithelial-Mesenchymal Transition. Frontiers in Oncology. 10. 1685–1685. 11 indexed citations
6.
Liu, Rong‐Zong, Xuejian Zhou, Lujia Zou, et al.. (2019). Clinicopathological and prognostic significance of preoperative plasma fibrinogen level in patients with upper urinary tract urothelial carcinoma: A retrospective tumor marker prognostic study. International Journal of Surgery. 65. 88–93. 13 indexed citations
7.
Hu, Mengbo, et al.. (2019). First-time versus recurrent penoscrotal extramammary Paget's disease: Clinicopathological characteristics and risk factors in 164 Chinese male patients. Indian Journal of Dermatology Venereology and Leprology. 86(2). 134–134. 2 indexed citations
8.
Yang, Tian, Xiaobo Wu, Jimeng Hu, et al.. (2018). Maternal High-Fat Diet Promotes the Development and Progression of Prostate Cancer in Transgenic Adenocarcinoma Mouse Prostate Offspring. Cellular Physiology and Biochemistry. 47(5). 1862–1870. 17 indexed citations
9.
Ding, Qiang, Fei Wu, Shanhua Mao, et al.. (2017). Aldosterone induces inflammatory cytokines in penile corpus cavernosum by activating the NF-κB pathway. Asian Journal of Andrology. 20(1). 24–24. 7 indexed citations
10.
Yang, Tian, et al.. (2017). The Evaluation of Risk Factors for Postoperative Infectious Complications after Percutaneous Nephrolithotomy. BioMed Research International. 2017. 1–7. 39 indexed citations
11.
Hu, Mengbo, Hua Xu, Wenhui Zhu, et al.. (2017). High-fat diet‑induced adipokine and cytokine alterations promote the progression of prostate cancer in�vivo and in�vitro. Oncology Letters. 15(2). 1607–1615. 24 indexed citations
12.
Wei, Bingbing, Jimeng Hu, Yuanyuan Mi, et al.. (2017). TRAF2 is a Valuable Prognostic Biomarker in Patients with Prostate Cancer. Medical Science Monitor. 23. 4192–4204. 19 indexed citations
13.
Hu, Jimeng, Wenhui Zhu, Bingbing Wei, et al.. (2016). Antitumoral action of icaritin in LNCaP prostate cancer cells by regulating PEA3/HER2/AR signaling. Anti-Cancer Drugs. 27(10). 944–952. 16 indexed citations
15.
Hu, Jimeng, et al.. (2016). A novel anticancer agent icaritin inhibited proinflammatory cytokines in TRAMP mice. International Urology and Nephrology. 48(10). 1649–1655. 10 indexed citations
17.
Bai, Peide, Hua Xu, Wenhui Zhu, et al.. (2015). Body mass index is associated with higher Gleason score and biochemical recurrence risk following radical prostatectomy in Chinese men: a retrospective cohort study and meta-analysis. World Journal of Surgical Oncology. 13(1). 311–311. 18 indexed citations
18.
Hu, Jimeng, Limin Zhang, Lujia Zou, et al.. (2015). Role of inflammation in benign prostatic hyperplasia development among Han Chinese: A population‐based and single‐institutional analysis. International Journal of Urology. 22(12). 1138–1142. 15 indexed citations
19.
Wu, Yeming, et al.. (2014). Preliminary analysis of stem cell-like cells in human neuroblastoma. World Journal of Pediatrics. 11(1). 54–60. 9 indexed citations
20.
Xu, Guofeng, et al.. (2013). Botryoid Wilms’ tumor: a case report and review of the literature. World Journal of Surgical Oncology. 11(1). 102–102. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026